• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性HIV-1感染期间表型幼稚CD4(+) T细胞的Th17极化受损及早期抗逆转录病毒治疗的潜在恢复作用

Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.

作者信息

DaFonseca Sandrina, Niessl Julia, Pouvreau Sylvia, Wacleche Vanessa Sue, Gosselin Annie, Cleret-Buhot Aurélie, Bernard Nicole, Tremblay Cécile, Jenabian Mohammad-Ali, Routy Jean-Pierre, Ancuta Petronela

机构信息

Faculty of Medicine, Department of Microbiology, Infectiology and Immunology, Université de Montréal, Montreal, QC, Canada.

CHUM-Research Centre, 900 rue Saint-Denis, Tour Viger R, room R09.416, Montreal, QC, H2X 0A9, Canada.

出版信息

Retrovirology. 2015 Apr 30;12:38. doi: 10.1186/s12977-015-0164-6.

DOI:10.1186/s12977-015-0164-6
PMID:25924895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4438463/
Abstract

BACKGROUND

Depletion of mucosal Th17 cells during HIV/SIV infections is a major cause for microbial translocation, chronic immune activation, and disease progression. Mechanisms contributing to Th17 deficit are not fully elucidated. Here we investigated alterations in the Th17 polarization potential of naive-like CD4(+) T-cells, depletion of Th17-commited subsets during HIV pathogenesis, and Th17 restoration in response to antiretroviral therapy (ART).

RESULTS

Peripheral blood CD4(+) T-cells expressing a naive-like phenotype (CD45RA(+)CCR7(+)) from chronically HIV-infected subjects receiving ART (CI on ART; median CD4 counts 592 cells/μl; viral load: <50 HIV-RNA copies/ml; time since infection: 156 months) compared to uninfected controls (HIV-) were impaired in their survival and Th17 polarization potential in vitro. In HIV- controls, IL-17A-producing cells mainly originated from naive-like T-cells with a regulatory phenotype (nTregs: CD25(high)CD127(-)FoxP3(+)) and from CD25(+)CD127(+)FoxP3(-) cells (DP, double positive). Th17-polarized conventional naive CD4(+) T-cells (nT: CD25(-)CD127(+)FoxP3(-)) also produced IL17A, but at lower frequency compared to nTregs and DP. In CI on ART subjects, the frequency/counts of nTreg and DP were significantly diminished compared to HIV- controls, and this paucity was further associated with decreased proportions of memory T-cells producing IL-17A and expressing Th17 markers (CCR6(+)CD26(+)CD161(+), mTh17). nTregs and DP compared to nT cells harbored superior levels of integrated/non-integrated HIV-DNA in CI on ART subjects, suggesting that permissiveness to integrative/abortive infection contributes to impaired survival and Th17 polarization of lineage-committed cells. A cross-sectional study in CI on ART subjects revealed that nTregs, DP and mTh17 counts were negatively correlated with the time post-infection ART was initiated and positively correlated with nadir CD4 counts. Finally, a longitudinal analysis in a HIV primary infection cohort demonstrated a tendency for increased nTreg, DP, and mTh17 counts with ART initiation during the first year of infection.

CONCLUSIONS

These results support a model in which the paucity of phenotypically naive nTregs and DP cells, caused by integrative/abortive HIV infection and/or other mechanisms, contributes to Th17 deficiency in HIV-infected subjects. Early ART initiation, treatment intensification with integrase inhibitors, and/or other alternative interventions aimed at preserving/restoring the pool of cells prone to acquire Th17 functions may significantly improve mucosal immunity in HIV-infected subjects.

摘要

背景

HIV/SIV感染期间黏膜Th17细胞耗竭是微生物易位、慢性免疫激活和疾病进展的主要原因。导致Th17细胞缺乏的机制尚未完全阐明。在此,我们研究了初始样CD4(+)T细胞的Th17极化潜能的改变、HIV发病过程中Th17定向亚群的耗竭以及抗逆转录病毒治疗(ART)后Th17的恢复情况。

结果

与未感染的对照组(HIV-)相比,接受ART的慢性HIV感染受试者(ART治疗的慢性感染者;CD4计数中位数为592个细胞/μl;病毒载量:<50个HIV-RNA拷贝/ml;感染时间:156个月)外周血中表达初始样表型(CD45RA(+)CCR7(+))的CD4(+)T细胞在体外的存活和Th17极化潜能受损。在HIV-对照组中,产生IL-17A的细胞主要来源于具有调节表型的初始样T细胞(nTregs:CD25(高)CD127(-)FoxP3(+))和CD25(+)CD127(+)FoxP3(-)细胞(DP,双阳性)。Th17极化的传统初始CD4(+)T细胞(nT:CD25(-)CD127(+)FoxP3(-))也产生IL17A,但与nTregs和DP相比频率较低。在接受ART治疗的慢性感染者中,与HIV-对照组相比,nTreg和DP的频率/数量显著减少,这种缺乏还与产生IL-17A并表达Th17标志物(CCR6(+)CD26(+)CD161(+),mTh17)的记忆T细胞比例降低有关。与nT细胞相比,接受ART治疗的慢性感染者中的nTregs和DP含有更高水平的整合/未整合HIV-DNA,这表明对整合性/顿挫性感染的易感性导致了定向细胞的存活受损和Th17极化。对接受ART治疗的慢性感染者的横断面研究表明,nTregs、DP和mTh17计数与开始ART治疗后的感染时间呈负相关,与最低点CD4计数呈正相关。最后,对HIV原发性感染队列的纵向分析表明,在感染的第一年开始ART治疗后,nTreg、DP和mTh17计数有增加的趋势。

结论

这些结果支持一种模型,即由整合性/顿挫性HIV感染和/或其他机制导致的表型初始nTregs和DP细胞缺乏,促成了HIV感染受试者的Th17细胞缺乏。早期开始ART治疗、使用整合酶抑制剂加强治疗和/或其他旨在保存/恢复易于获得Th17功能的细胞池的替代干预措施,可能会显著改善HIV感染受试者的黏膜免疫。

相似文献

1
Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.慢性HIV-1感染期间表型幼稚CD4(+) T细胞的Th17极化受损及早期抗逆转录病毒治疗的潜在恢复作用
Retrovirology. 2015 Apr 30;12:38. doi: 10.1186/s12977-015-0164-6.
2
Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.在接受抗逆转录病毒治疗的印度尼西亚艾滋病患者中,初始和记忆性CD4⁺ T细胞受到的影响存在差异。
Viral Immunol. 2016 Apr;29(3):176-83. doi: 10.1089/vim.2015.0108.
3
Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.接受抗逆转录病毒治疗但存在CD4+T细胞缺陷的HIV患者,其初始CD4+T细胞中的白细胞介素-7信号缺陷与T细胞活化和衰老相关。
AIDS. 2014 Mar 27;28(6):821-30. doi: 10.1097/QAD.0000000000000213.
4
New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy.关于抗逆转录病毒治疗期间促成HIV-1持续存在的Th17亚群异质性的新见解。
Retrovirology. 2016 Aug 24;13(1):59. doi: 10.1186/s12977-016-0293-6.
5
Immune signatures for HIV-1 and HIV-2 induced CD4T cell dysregulation in an Indian cohort.在印度队列中,HIV-1 和 HIV-2 诱导的 CD4T 细胞失调的免疫特征。
BMC Infect Dis. 2019 Feb 11;19(1):135. doi: 10.1186/s12879-019-3743-7.
6
Longitudinal Analysis of Peripheral and Colonic CD161 CD4 T Cell Dysfunction in Acute HIV-1 Infection and Effects of Early Treatment Initiation.急性 HIV-1 感染中外周和结肠 CD161+CD4 T 细胞功能障碍的纵向分析及早期治疗干预的影响
Viruses. 2020 Dec 11;12(12):1426. doi: 10.3390/v12121426.
7
Alteration of CCR6CD95CD4 naïve T cells in HIV-1 infected patients: Implication for clinical practice.HIV-1 感染患者中 CCR6+CD95+CD4+幼稚 T 细胞的改变:对临床实践的意义。
Cell Immunol. 2018 May;327:47-53. doi: 10.1016/j.cellimm.2018.02.004. Epub 2018 Feb 10.
8
Excessive conversion and impaired thymic output contribute to disturbed regulatory T-cell homeostasis in AIDS patients with low CD4 cell counts.过度转换和胸腺输出受损导致 CD4 计数低的艾滋病患者调节性 T 细胞稳态失调。
AIDS. 2013 Apr 24;27(7):1059-69. doi: 10.1097/QAD.0b013e32835e2b99.
9
Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.在早期或慢性HIV-1感染期间开始接受抗逆转录病毒治疗(ART)的患者中,CD4+和CD8+T细胞的功能失调表型具有可比性。
Medicine (Baltimore). 2016 Jun;95(23):e3738. doi: 10.1097/MD.0000000000003738.
10
CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.CD127和CD25的表达定义了在HIV感染期间差异耗竭的CD4+ T细胞亚群。
J Immunol. 2008 Apr 15;180(8):5582-92. doi: 10.4049/jimmunol.180.8.5582.

引用本文的文献

1
Benefit delayed immunosenescence by regulating CD4T cells: A promising therapeutic target for aging-related diseases.通过调节 CD4T 细胞来延缓免疫衰老:一种有前途的与衰老相关疾病的治疗靶点。
Aging Cell. 2024 Oct;23(10):e14317. doi: 10.1111/acel.14317. Epub 2024 Aug 18.
2
Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection.在接受抗逆转录病毒治疗的 HIV-1 感染期间,Th17 细胞和非经典单核细胞的改变作为亚临床冠状动脉粥样硬化的特征。
Cells. 2024 Jan 15;13(2):157. doi: 10.3390/cells13020157.
3
The many faces of parasite calreticulin.

本文引用的文献

1
Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.在急性HIV感染早期启动抗逆转录病毒治疗可保留黏膜Th17功能并逆转HIV相关的免疫激活。
PLoS Pathog. 2014 Dec 11;10(12):e1004543. doi: 10.1371/journal.ppat.1004543. eCollection 2014 Dec.
2
Comment on "differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors".关于“从谱系定向的初始前体细胞分化产生白细胞介素-17的效应性和调节性人类T细胞”的评论
J Immunol. 2014 Oct 1;193(7):3181. doi: 10.4049/jimmunol.1401944.
3
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.
寄生虫钙网蛋白的多面性。
Front Immunol. 2023 Mar 10;14:1101390. doi: 10.3389/fimmu.2023.1101390. eCollection 2023.
4
Discrete Plasma Cytokine Profiles Among Pregnant Women in Botswana by Chlamydia trachomatis Infection, Human Immunodeficiency Virus Status, and Gestational Age.博茨瓦纳孕妇沙眼衣原体感染、人类免疫缺陷病毒状态和孕周的离散血浆细胞因子谱
J Infect Dis. 2022 Sep 28;226(7):1298-1299. doi: 10.1093/infdis/jiac302.
5
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients.直接作用抗病毒药物治愈 HCV 可改善 HIV/HCV 合并感染患者的肝脏和免疫标志物。
Front Immunol. 2021 Aug 23;12:723196. doi: 10.3389/fimmu.2021.723196. eCollection 2021.
6
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.在 HIV 得到控制的患者中,维持胃肠道黏膜屏障功能和微生物组。
Front Immunol. 2021 May 31;12:688886. doi: 10.3389/fimmu.2021.688886. eCollection 2021.
7
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients.基于干扰素的治疗清除 HCV 并不能完全恢复 HIV/HCV 合并感染患者 PBMC 中的基因表达。
J Biomed Sci. 2021 Mar 30;28(1):23. doi: 10.1186/s12929-021-00718-6.
8
MicroRNA-146a-5p enhances T helper 17 cell differentiation via decreasing a disintegrin and metalloprotease 17 level in primary sjögren's syndrome.miRNA-146a-5p 通过降低原发性干燥综合征中 ADAM17 的水平促进辅助性 T 细胞 17 分化。
Bioengineered. 2021 Dec;12(1):310-324. doi: 10.1080/21655979.2020.1870321.
9
Simian Immunodeficiency Virus Infects Functionally Polarized Memory CD4 T Cells Equivalently .猴免疫缺陷病毒感染功能极化的记忆性 CD4 T 细胞等效。
J Virol. 2019 Apr 17;93(9). doi: 10.1128/JVI.02163-18. Print 2019 May 1.
10
Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.根据肝脏硬度状态分析HIV/HCV合并感染患者的免疫系统失调情况
Cells. 2018 Nov 2;7(11):196. doi: 10.3390/cells7110196.
在原发性HIV-1感染时开始的长期抗逆转录病毒治疗会影响HIV-1感染的CD4 T细胞储存库的大小、组成和衰减动力学。
J Virol. 2014 Sep 1;88(17):10056-65. doi: 10.1128/JVI.01046-14. Epub 2014 Jun 25.
4
Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors.从谱系定型的幼稚前体中分化出产生 IL-17 的效应和调节性人 T 细胞。
J Immunol. 2014 Aug 1;193(3):1047-54. doi: 10.4049/jimmunol.1302936. Epub 2014 Jun 23.
5
Phenotype and susceptibility to HIV infection of CD4+ Th17 cells in the human female reproductive tract.人类女性生殖道中CD4+ Th17细胞的表型及对HIV感染的易感性
Mucosal Immunol. 2014 Nov;7(6):1375-85. doi: 10.1038/mi.2014.26. Epub 2014 Apr 23.
6
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.白细胞介素-7给药后慢性HIV感染中结肠和全身炎症的减轻。
PLoS Pathog. 2014 Jan 30;10(1):e1003890. doi: 10.1371/journal.ppat.1003890. eCollection 2014 Jan.
7
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.细胞焦亡导致 HIV-1 感染中 CD4 T 细胞耗竭。
Nature. 2014 Jan 23;505(7484):509-14. doi: 10.1038/nature12940.
8
Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity.由于结肠树突状细胞中酰氧基酰基水解酶缺乏导致共生 LPS 失活改变,从而损害黏膜 Th17 免疫。
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):373-8. doi: 10.1073/pnas.1311987111. Epub 2013 Dec 16.
9
Elevated CD57 and CD95 expressions are associated with lower numbers of CD4⁺ recent thymic emigrants in HIV-1 infected immune responders following antiretroviral treatment.CD57 和 CD95 表达水平升高与 HIV-1 感染免疫应答者抗逆转录病毒治疗后 CD4⁺ 近期胸腺迁出细胞数量减少有关。
Immunol Lett. 2014 Mar-Apr;158(1-2):1-6. doi: 10.1016/j.imlet.2013.11.014. Epub 2013 Nov 28.
10
Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.HIV 进展者和精英控制者中色氨酸分解代谢和 Th17/Treg 平衡的差异。
PLoS One. 2013 Oct 16;8(10):e78146. doi: 10.1371/journal.pone.0078146. eCollection 2013.